Jiean Xu

1.3k total citations
25 papers, 526 citations indexed

About

Jiean Xu is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Jiean Xu has authored 25 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Physiology. Recurrent topics in Jiean Xu's work include Adenosine and Purinergic Signaling (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Immune cells in cancer (5 papers). Jiean Xu is often cited by papers focused on Adenosine and Purinergic Signaling (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Immune cells in cancer (5 papers). Jiean Xu collaborates with scholars based in China, United States and Russia. Jiean Xu's co-authors include Yuqing Huo, Qiuhua Yang, Qian Ma, Zhiping Liu, Mei Hong, Yaqi Zhou, Xiaoxiao Mao, Yapeng Cao, Xiaoyu Zhang and David Fulton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Jiean Xu

23 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiean Xu China 12 240 152 93 89 83 25 526
Baraa Noueihed Canada 11 258 1.1× 110 0.7× 77 0.8× 177 2.0× 50 0.6× 14 622
Shuhua Fu China 9 310 1.3× 56 0.4× 70 0.8× 279 3.1× 74 0.9× 15 538
Siyuan He China 8 205 0.9× 84 0.6× 42 0.5× 52 0.6× 123 1.5× 18 401
Yaowu Qin China 12 325 1.4× 37 0.2× 67 0.7× 248 2.8× 144 1.7× 18 566
Thomas Fredrick United States 9 244 1.0× 50 0.3× 42 0.5× 226 2.5× 68 0.8× 15 459
Liping Xue China 13 203 0.8× 99 0.7× 33 0.4× 42 0.5× 86 1.0× 21 403
Dorothy T. Pei United States 9 229 1.0× 54 0.4× 18 0.2× 132 1.5× 103 1.2× 10 543
G. Menicucci United States 5 207 0.9× 42 0.3× 122 1.3× 272 3.1× 139 1.7× 7 566
Sofia Theodoropoulou United Kingdom 16 286 1.2× 79 0.5× 59 0.6× 452 5.1× 35 0.4× 38 797
Karen Frudd United Kingdom 7 230 1.0× 53 0.3× 26 0.3× 23 0.3× 96 1.2× 8 467

Countries citing papers authored by Jiean Xu

Since Specialization
Citations

This map shows the geographic impact of Jiean Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiean Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiean Xu more than expected).

Fields of papers citing papers by Jiean Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiean Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiean Xu. The network helps show where Jiean Xu may publish in the future.

Co-authorship network of co-authors of Jiean Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiean Xu. A scholar is included among the top collaborators of Jiean Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiean Xu. Jiean Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yaqi, Dingwei Zhao, Qian Ma, et al.. (2025). Endothelial adenosine receptor 2A loss alleviates diabetic vascular calcification by blocking CREB1-SNAI1-driven EndMT. Pharmacological Research. 221. 107981–107981.
2.
Tu, Ly, et al.. (2025). Long-Acting and Stapled GLP-1R/GIPR/GCGR Triple Agonist for the Treatment of Obesity and Atherosclerosis. Journal of Medicinal Chemistry. 68(15). 16578–16592. 1 indexed citations
3.
Zhou, Yaqi, Dingwei Zhao, Qian Ma, et al.. (2025). Targeting adenosine 2A receptor signaling suppresses vascular calcification by restraining smooth muscle osteogenic differentiation. Pharmacological Research. 221. 108012–108012.
4.
Yang, Qiuhua, Qian Ma, Zhidan Zhang, et al.. (2024). Inactivation of adenosine receptor 2A suppresses endothelial-to-mesenchymal transition and inhibits subretinal fibrosis in mice. Science Translational Medicine. 16(737). eadk3868–eadk3868. 9 indexed citations
5.
Zhou, Yaqi, Qiuhua Yang, Jiean Xu, et al.. (2024). Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition. Pharmacological Research. 203. 107156–107156. 10 indexed citations
6.
Xu, Jiean, Zhiping Liu, Qiuhua Yang, et al.. (2024). Adenosine kinase inhibition protects mice from abdominal aortic aneurysm via epigenetic modulation of VSMC inflammation. Cardiovascular Research. 120(10). 1202–1217. 6 indexed citations
7.
Zhang, Ning, Yuqing Li, Lisheng Zhang, et al.. (2024). Paeonol prevents sepsis-associated encephalopathy via regulating the HIF1A pathway in microglia. International Immunopharmacology. 143(Pt 1). 113287–113287. 1 indexed citations
8.
9.
Zhang, Min, Caiping Wang, Jiean Xu, et al.. (2022). Adenosine kinase promotes post-infarction cardiac repair by epigenetically maintaining reparative macrophage phenotype. Journal of Molecular and Cellular Cardiology. 174. 88–100. 3 indexed citations
10.
Da, Qingen, Mingming Ren, Lei Huang, et al.. (2022). Identification and Validation of a Ferroptosis-Related Signature for Predicting Prognosis and Immune Microenvironment in Papillary Renal Cell Carcinoma. SHILAP Revista de lepidopterología. 7 indexed citations
11.
Liu, Zhiping, Huidong Shi, Jiean Xu, et al.. (2022). Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy. JCI Insight. 7(23). 36 indexed citations
12.
Liu, Dong, Lijun Zhao, Xuechun Wang, et al.. (2022). A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy. Theranostics. 12(18). 7788–7803. 13 indexed citations
13.
Liu, Zhiping, Xiaoxiao Mao, Qiuhua Yang, et al.. (2022). Suppression of myeloid PFKFB3‐driven glycolysis protects mice from choroidal neovascularization. British Journal of Pharmacology. 179(22). 5109–5131. 28 indexed citations
14.
Singla, Bhupesh, Hui‐Ping Lin, Jiean Xu, et al.. (2021). Loss of myeloid cell-specific SIRPα, but not CD47, attenuates inflammation and suppresses atherosclerosis. Cardiovascular Research. 118(15). 3097–3111. 41 indexed citations
15.
Yang, Qiuhua, Qian Ma, Jiean Xu, et al.. (2021). Prkaa1 Metabolically Regulates Monocyte/Macrophage Recruitment and Viability in Diet-Induced Murine Metabolic Disorders. Frontiers in Cell and Developmental Biology. 8. 611354–611354. 8 indexed citations
16.
Xu, Jiean, Lina Wang, Qiuhua Yang, et al.. (2021). Deficiency of Myeloid Pfkfb3 Protects Mice From Lung Edema and Cardiac Dysfunction in LPS-Induced Endotoxemia. Frontiers in Cardiovascular Medicine. 8. 745810–745810. 14 indexed citations
17.
Yang, Qiuhua, Jiean Xu, Qian Ma, et al.. (2021). Disruption of endothelial Pfkfb3 ameliorates diet-induced murine insulin resistance. Journal of Endocrinology. 250(3). 93–104. 8 indexed citations
18.
Wang, Lina, Xiaoyu Zhang, Yapeng Cao, et al.. (2020). Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia‐induced pulmonary hypertension. British Journal of Pharmacology. 178(5). 1055–1072. 31 indexed citations
19.
Liu, Zhiping, Jiean Xu, Qian Ma, et al.. (2020). Glycolysis links reciprocal activation of myeloid cells and endothelial cells in the retinal angiogenic niche. Science Translational Medicine. 12(555). 94 indexed citations
20.
Wang, Lina, Yapeng Cao, Boris Gorshkov, et al.. (2019). Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia. Pharmacological Research. 146. 104292–104292. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baraa Noueihed Breakdown of academic impact, for papers by Shuhua Fu Breakdown of academic impact, for papers by Siyuan He Breakdown of academic impact, for papers by Yaowu Qin Breakdown of academic impact, for papers by Thomas Fredrick Breakdown of academic impact, for papers by Liping Xue Breakdown of academic impact, for papers by Dorothy T. Pei Breakdown of academic impact, for papers by G. Menicucci Breakdown of academic impact, for papers by Sofia Theodoropoulou Breakdown of academic impact, for papers by Karen Frudd
Rankless by CCL
2026